Heron Therapeutics
HRTX
#8261
Rank
HK$1.86 B
Marketcap
HK$10.19
Share price
0.00%
Change (1 day)
-25.14%
Change (1 year)

Heron Therapeutics (HRTX) - Total debt

Total debt on the balance sheet as of September 2025 : HK$1.09 Billion

According to Heron Therapeutics's latest financial reports the company's total debt is HK$1.09 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Heron Therapeutics - Total debt on balance sheet (from 1996 to 2025)

Total debt by year

Year Total debt Change
2024-12-31HK$1.38 B-1.63%
2023-12-31HK$1.40 B14.02%
2022-12-31HK$1.23 B-1.07%
2021-12-31HK$1.24 B551.86%
2020-12-31HK$0.19 B23.77%
2019-12-31HK$0.15 B330.34%
2018-12-31HK$35.81 M-84.02%
2017-12-31HK$0.22 B-45.38%
2016-12-31HK$0.41 B2282.41%
2015-12-31HK$17.22 M38.95%
2014-12-31HK$12.39 M55.95%
2013-12-31HK$7.94 M108.42%
2012-12-31HK$3.81 M376.7%
2011-12-31HK$0.79 M
1999-12-31HK$25.63 M6.74%
1998-12-31HK$24.01 M-44.66%
1997-12-31HK$43.39 M-20.98%
1996-12-31HK$54.91 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Alkermes
ALKS
HK$0.55 B-49.02%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Pacira Biosciences
PCRX
HK$3.30 B 202.83%๐Ÿ‡บ๐Ÿ‡ธ USA
Nektar Therapeutics
NKTR
HK$0.71 B-34.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
HK$3.50 B 221.12%๐Ÿ‡บ๐Ÿ‡ธ USA
SurModics
SRDX
HK$0.25 B-76.80%๐Ÿ‡บ๐Ÿ‡ธ USA